Interestingly, KIFC1 still participates in cisplatin resistance in bladder cancer [22], docetaxel resistance in breast cancer [24] and prostate cancer [25], and temozolomide (TMZ) resistance in glioblastoma [26]. This evidence concerns the gene KIFC1 and breast cancer.